- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Treatment Options
Total 63564 results
-
Bristol-Myers SquibbCompletedHepatitis C VirusAustralia, Sweden, United States, Canada, France, Germany, Denmark, Mexico, Italy, Puerto Rico, Egypt
-
Regeneron PharmaceuticalsSanofiCompletedHypercholesterolemiaUnited States, France, Italy, Germany, Spain, Mexico, Canada, United Kingdom, Australia
-
Eisai Inc.CompletedPartial Onset SeizuresFrance, United Kingdom, Germany, Denmark, Czech Republic, Norway, Sweden, Ireland
-
Emory UniversityCompleted
-
GlaxoSmithKlineCompleted
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompletedAdvanced Solid TumoursCanada
-
AstraZenecaNektar TherapeuticsCompletedOpioid Induced Constipation (OIC)United States
-
Tibotec Pharmaceuticals, IrelandCompletedHIV-1United States, Belgium, Germany, Taiwan, Spain, Mexico, Turkey, Canada, Netherlands, Denmark, Greece, Sweden, Korea, Republic of, Russian Federation, Puerto Rico, Luxembourg
-
Eisai Inc.Approved for marketingMetastatic Breast CancerCanada, Belgium, France
-
US Department of Veterans AffairsCanadian Institutes of Health Research (CIHR); Medical Research CouncilCompletedHIV Infections | AIDSUnited States, Puerto Rico
-
Genzyme, a Sanofi CompanyCompletedThyroid CancerSpain, Germany, Italy, Portugal
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Completed
-
Tibotec Pharmaceuticals, IrelandCompletedHIVUnited States, France, Argentina, Chile, Mexico, Costa Rica, Panama, Brazil, Puerto Rico, Thailand
-
University of New MexicoCompletedPatient Satisfaction | Fecal Incontinence | CounsellingUnited States
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Terminated
-
Gilead SciencesCompletedHepatitis C, ChronicUnited States, Puerto Rico
-
Gilead SciencesCompletedHepatitis C, ChronicUnited States, United Kingdom, France, Germany, Netherlands, Belgium, Austria, Poland
-
Gilead SciencesApproved for marketing
-
Gilead SciencesCompletedHepatitis C, ChronicUnited States, Puerto Rico
-
Astellas Pharma IncTerminated
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedAcquired Immunodeficiency SyndromeSouth Africa
-
Oregon Research InstituteNational Institute of Mental Health (NIMH)Completed
-
Genomic Health®, Inc.Registrat-MapiCompletedBreast CancerFrance
-
MethylGene Inc.CompletedVulvovaginal CandidiasisUnited States
-
Maastricht Radiation OncologyMaastricht University Medical CenterWithdrawnStage 4 Cancer
-
PfizerTerminated
-
Novartis PharmaceuticalsCompletedGastrointestinal Stromal TumorsUnited States, Australia, Germany, Spain, Korea, Republic of, Canada, France, Poland, Austria, Netherlands, Italy, Czech Republic, Switzerland
-
Astellas Pharma IncAstellas Pharma US, Inc.CompletedRheumatoid ArthritisUnited States, Canada
-
Tioga PharmaceuticalsRTI Health SolutionsCompletedIrritable Bowel SyndromeUnited States
-
Novartis PharmaceuticalsCompletedGenital HerpesUnited States, Germany, Australia, Canada
-
Tibotec Pharmaceuticals, IrelandCompleted
-
Tibotec Pharmaceuticals, IrelandCompleted
-
University of SydneyNational Health and Medical Research Council, Australia; Sydney South West... and other collaboratorsCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...Terminated
-
Teva Pharmaceuticals USACompleted
-
Threshold PharmaceuticalsTerminatedBenign Prostatic HyperplasiaUnited States
-
XOMA (US) LLCCompletedRheumatoid ArthritisUnited States
-
Amsterdam UMCZonMw: The Netherlands Organisation for Health Research and DevelopmentNot yet recruitingPre-Eclampsia | HELLP Syndrome | Pre-eclampsia or Eclampsia With Pre-existing Hypertension | HELLP | Pre-Eclampsia; Complicating Pregnancy | Pre-Eclampsia Onset Less Than 37 Weeks | Pre-Eclampsia as Antepartum Condition | Pre-Eclampsia; Affecting Fetus | HELLP Syndrome Complicating Pregnancy
-
Bruce CreeKyverna TherapeuticsNot yet recruitingProgressive Multiple SclerosisUnited States
-
McGill University Health Centre/Research Institute...Not yet recruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)Not yet recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Refractory Grade 1 Follicular Lymphoma | Refractory Grade 2 Follicular Lymphoma | Refractory Grade 3a Follicular LymphomaUnited States
-
China Medical University HospitalRecruitingRespiratory Failure | Morality | Delayed Gastric Emptying | Organ Failure, Multiple | IndigestionTaiwan
-
Grit BiotechnologyRecruiting
-
BayerNot yet recruitingAdvanced Non-small Cell Lung Cancer | HER2 MutationUnited States, Korea, Republic of, Belgium, China, Japan, Taiwan, Denmark, Germany, Israel, Italy, United Kingdom, Bulgaria, Portugal, Switzerland, Greece, Turkey, Sweden, France, Singapore, Mexico, Spain, Netherlands, Poland, Brazil, A... and more
-
Region StockholmRecruitingBile Duct Cancer | Duodenal Cancer | Pancreatic Cancer Non-resectable | Papillary CarcinomaSweden
-
Fundacio De Recerca Del Instituto De Microcirugia...Recruiting
-
University Health Network, TorontoNot yet recruitingLocally Advanced Pancreatic Adenocarcinoma